- Structural-functional analyses of the huntingtin/HAP40 complex in <em>Drosophila</em> and humans
- Presymptomatic targeted circuit manipulation for ameliorating Huntington's disease pathogenesis
- Transcriptomic analysis of intracellular RNA granules and small extracellular vesicles: Unmasking their overlap in a cell model of Huntington's Disease
- Developmental alterations of indirect-pathway medium spiny neurons in mouse models of Huntington's disease
- Progressively reduced cerebral oxygen metabolism and elevated plasma NfL levels in the zQ175DN mouse model of Huntington disease
- Neurodegenerative diseases: Epigenetic regulatory mechanisms and therapeutic potential
- Co-Activation Patterns in Neonates using High-Density Diffuse Optical Tomography: Insights into Early Dynamic Functional Connectivity
- The Adequacy of Vancomycin Initial Dosing in CRBSI for Hemodialysis Patients at Hospital Pakar Sultanah Fatimah, Muar, Johor
- Associations between Cardiovascular Risk Factors and Neurofilament Light Levels Among U.S. Mexican American Adults
- The breaking point where repeat expansion triggers neuronal collapse in Huntington's disease
- Early Alterations of Motor Learning and Corticostriatal Network Activity in a Huntington's Disease Mouse Model
- CAG Repeat Instability and Region-Specific Gene Expression Changes in the SCA12 Brain
- Unraveling the Roles of UBE3A in Neurodevelopment and Neurodegeneration
- Progress in AAV-Mediated In Vivo Gene Therapy and Its Applications in Central Nervous System Diseases
- Targeting cGAS-STING signaling: a potential therapeutic approach for the management of Huntington's disease
- Anle138b ameliorates pathological phenotypes in mouse and cellular models of Huntington's disease
- Modulation of autism-associated serotonin transporters by palmitoylation: Insights into the molecular pathogenesis and targeted therapies for autism spectrum disorder
- Corrigendum to "Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6/2 mouse model of Huntington's disease" [Neurobiology of Disease 108 (2017) Pages 29-44]
- Age-Related Neurodegenerative Diseases: A Stem Cell's Perspective
- Local modulation of sleep slow waves depends on timing between auditory stimuli
- Electroacupuncture Neural Stimulation Mitigates Bladder Dysfunction and Mechanical Allodynia in Cyclophosphamide Induced Cystitis through Downregulation of the BDNF-TrkB Signaling Pathway
- Intersecting impact of CAG repeat and Huntingtin knockout in stem cell-derived cortical neurons
- Seven Hub Genes Associated with Huntington's Disease and Diagnostic and Therapeutic Potentials Identified by Computational Biology
- SNAP-25: A biomarker of synaptic loss in neurodegeneration
- Biallelic genome engineering to create isogenic induced pluripotent stem cells modelling Huntington's disease
- Melatonin for Huntington's Disease (HD) gene carriers with HD-related sleep disturbance - A pilot study
- The Safety Profile of Pridopidine, a Novel Sigma-1 Receptor Agonist for the Treatment of Huntington's Disease
- Tau levels in platelets isolated from Huntington's disease patients serve as a biomarker of disease severity
- Unraveling progressive verbal memory deficits in Huntington's disease: insights from the LASSI-L
- ASO targets DNA repair protein to combat Huntington disease
- Downregulation of Pten Improves Huntington's Disease Phenotype by Reducing Htt Aggregates and Cell Death
- Protective effects of diacerein against quinolinic acid-induced Huntington's disease-like symptoms in adult zebrafish by targeting GSK-3beta signalling
- Spiritual Well-Being and Phenoconversion in Huntington's Disease: Analysis from the Prospective Huntington at Risk Observational Study
- Nonlinear Assessment of Gait Signal Complexity in Neurodegenerative Disorders
- Systemic Neuroprotection by Chlorogenic Acid: Antioxidant and Anti-inflammatory Evaluation in Early Neurodegeneration Induced by 3-Nitropropionic Acid in Mice
- Unnatural foldamers as inhibitors of Aβ aggregation <em>via</em> stabilizing the Aβ helix
- Allelic Diversity, de novo CAG Expansions, and Intergenerational Instability at the HTT Locus in a clinical sample of Huntingtons Disease from India
- Action impulsivity and attention deficits in patients at an early stage of Huntington disease
- Sleep fragmentation, 24-hr rest-activity patterns, and cognitive function in premanifest Huntington's disease: An actigraphy study
- CellFIE: Integrating Pathway Discovery With Pooled Profiling of Perturbations Uncovers Pathways of Huntington's Disease, Including Genetic Modifiers of Neuronal Development and Morphology
- Topological Gait Analysis: A New Framework and Its Application to the Study of Human Gait
- Advanced strategies for enhancing the neuroprotective potential of curcumin: delivery systems and mechanistic insights in neurodegenerative disorders
- Daily variation in symptoms and functioning in Huntington disease: Feasibility and variability
- Synergistic neuroprotective and cognitive-enhancing effects of Walnut Peptide and Theanine in human brain organoid and mouse stress models
- The effect of a single session of tDCS on attention in pediatric acquired brain injury: Characterising inter-individual structural and functional network response variability
- Recent Progress of Triplex DNA Formation and Its Applications
- Neuraxial Analgesia and Anesthesia for Labor and Cesarean Delivery in a Patient with Juvenile Huntington Disease: A Case Report
- Cost Trends of New-To-Market Neurologic Medications: An Insurance Claims Database Analysis
- Anti-inflammatory and antioxidant effects of baicalein: targeting Nrf2, and NFqB in neurodegenerative disease
- Tandem repeat expansions and copy number variations as risk factors and diagnostic tools for amyotrophic lateral sclerosis
- Upcoming meetings related to Huntington's disease
- Study insights in the role of PGC-1α in neurological diseases: mechanisms and therapeutic potential
- The therapeutic potential of (R)-carvedilol in Huntington's disease through enhancement of autophagy-lysosomal pathway via GSK-3beta inhibition
- MIMI-ONET: Multi-Modal image augmentation via Butterfly Optimized neural network for Huntington DiseaseDetection
- The Role of MicroRNAs in Neurodegeneration: Insights from Huntington's Disease
- The Role of Brain-Derived Neurotrophic Factor as an Essential Mediator in Neuronal Functions and the Therapeutic Potential of Its Mimetics for Neuroprotection in Neurologic and Psychiatric Disorders
- Inositol Phosphates and Synthesizing Enzymes: Implications in Neurodegenerative Disorders
- Genomic and Transcriptomic Approaches Advance the Diagnosis and Prognosis of Neurodegenerative Diseases
- Mechanistic insights into connexin-mediated neuroglia crosstalk in neurodegenerative diseases
- The Role of Amphibian AMPs Against Oxidative Stress and Related Diseases
- Analysis of Short Tandem Repeat Expansions in a Cohort of 12,496 Exomes from Patients with Neurological Diseases Reveals Variable Genotyping Rate Dependent on Exome Capture Kits
- Transcriptome Study in Sicilian Patients with Huntington's Disease
- Mosaicism in Short Tandem Repeat Disorders: A Clinical Perspective
- Long-Term Engraftment of Cryopreserved Human Neurons for In Vivo Disease Modeling in Neurodegenerative Disease
- Endothelial Dysfunction in Huntington's Disease: Pathophysiology and Therapeutic Implications
- Pepinemab: a SEMA4D antagonist for treatment of Huntington's and other neurodegenerative diseases
- Advances in Huntington's Disease Biomarkers: A 10-Year Bibliometric Analysis and a Comprehensive Review
- Combining Sampling Methods with Attractor Dynamics in Spiking Models of Head-Direction Systems
- Using wearable sensors and machine learning to assess upper limb function in Huntington's disease
- Mitochondrial Dysfunction in Neurodegenerative Diseases
- Human striatal progenitor cells that contain inducible safeguards and overexpress BDNF rescue Huntington's disease phenotypes
- Diagnostic role of circulating cell-free DNA in schizophrenia and neuro-degenerative disorders
- Combination therapy of mitochondria-targeted antioxidants and polyphenols for early intervention in Huntington's disease
- Intersecting impact of CAG repeat and Huntingtin knockout in stem cell-derived cortical neurons
- Recognizing familial Huntington's disease in an Asian cohort: Insights from the Philippines
- Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease
- Polyamines signalling pathway: A key player in unveiling the molecular mechanisms underlying Huntington's disease
- Genetic therapies for movement disorders - current status
- Real-world safety analysis of deutetrabenazine post-marketing: a disproportionality study leveraging the FDA Adverse Event Reporting System (FAERS) database
- Specific contribution of cognitive and motor impairments with functional capacity and dependence in Huntington's disease
- 'SpikeNburst' and 'Nicespike': Advanced Tools for Enhancing and Accelerating In Vitro High-Density Electrophysiology Analysis
- A spatial transcriptomics atlas of live donors reveals unique zonation patterns in the healthy human liver
- Multiple Copper Ions Bind to and Promote the Oligomerization of Huntingtin Protein with Nonpathological Repeat Expansions
- Short-chain fatty acids in Huntington's disease: Mechanisms of action and their therapeutic implications
- Studies on in vitro modulatory effects to base excision repair enzymes induced by small molecule binding to Deaminated CAG repeat hairpin
- Targeting natural antioxidant polyphenols to protect neuroinflammation and neurodegenerative diseases: a comprehensive review
- Mortality trends and disparities in adults with Huntington's disease in the United States
- Cognitive impairment in Huntington's disease and its impact on functioning: Concept elicitation and cognitive debriefing for the Huntington's Disease Everyday Functioning (Hi-DEF) scale
- Acceptance and commitment therapy with Huntington's disease: A narrative review and case report of a caregiver-assisted intervention
- Comparative analysis of neurofilament light chain in Huntington's disease like 2 and Huntington's disease
- Quality of care through the eyes of residents with Huntington's disease living in a nursing home: A qualitative explorative study
- Social cognition profile in early Huntington disease: Insight from neuropsychological assessment and structural neuroimaging
- Optogenetic restoration of neuron subtype-specific cortical activity ameliorates motor deficits in Huntington's Disease mice
- Huntington's disease at work: The effect of profession-specific requirements as related to clinical characteristics on work outcome
- Frequency of depression in Huntington's disease: A systematic review and meta-analysis
- Sleep-wake cycle and 24-h motor activity in early-mid Huntington's disease patients: An actigraphy-based study
- Study protocol for the iMarkHD study in individuals with Huntington's disease
- Through their eyes: A retrospective mixed-methods study on the experiences and support needs of children growing up with a parent with Huntington's disease
- Huntington's Disease Clinical Trials Update: September 2024
- Neuroimaging Techniques in Huntington's Disease: A Critical Review
RSS Feed – Literature
HDinHD > RSS Feed – Literature
